Stocksigma LogoStocksigma Logo

Sanofi India Q3'26 Results: Net Profit Surges 54% YoY; ₹75 Interim Dividend Declared

Sanofi India reported a 3.4% YoY rise in Q3'26 revenue from operations to ₹4,917 million, driven by 9% growth in its diabetes injectable portfolio, which

Sanofi India Q3'26 Results: Net Profit Surges 54% YoY; ₹75 Interim Dividend Declared

Sanofi India Ltd · Outcome · 30 Oct 2026, 12:02 am

Sanofi India Q3'26 Results: Net Profit Surges 54% YoY; ₹75 Interim Dividend Declared Sanofi India reported a 3.4% YoY rise in Q3'26 revenue from operations to ₹4,917 million, driven by 9% growth in its diabetes injectable portfolio, which holds a 55% market share. Net profit jumped 53.6% YoY to ₹1,167 million, supported by an 8% reduction in operating expenses and provision reversals. Profit before tax margin expanded to 34% from 29% in Q3'25. Additionally, the Board declared an interim dividend of ₹75 per equity share (face value ₹10), fixing the record date as 5th Nov'26.

Original exchange filing (PDF)

More announcements from Sanofi India Ltd

All Sanofi India Ltd announcements